Oya M - Search Results

1

Clinical efficacy and prognostic factors of tumor progression in Japanese patients with advanced renal cell carcinoma treated with sorafenib.

Kondo T, Nakazawa H, Oya M, Kimura G, Fujii Y, Hatano T, Kawata N, Kume H, Morita M, Nakajima K, Ohno Y, Okegawa T, Takahashi S, Wakumoto Y, Horie S, Yamaguchi R, Saito K, Murakami M. Kondo T, et al. Among authors: oya m. Jpn J Clin Oncol. 2015 Mar;45(3):274-80. doi: 10.1093/jjco/hyu200. Epub 2014 Nov 23. Jpn J Clin Oncol. 2015. PMID: 25420693 Clinical Trial.

2

[What is the impact of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma?].

Oya M, Murai M. Oya M, et al. Gan To Kagaku Ryoho. 2002 Oct;29(10):1732-7. Gan To Kagaku Ryoho. 2002. PMID: 12402422 Japanese.

3

Dexamethasone and interleukin-2 combination therapy for advanced renal cell carcinoma in a patient with paraneoplastic inflammatory syndrome.

Shinojima T, Oya M, Kohno H, Marumo K, Murai M. Shinojima T, et al. Among authors: oya m. Int J Urol. 2004 Jul;11(7):553-6. doi: 10.1111/j.1442-2042.2004.00831.x. Int J Urol. 2004. PMID: 15242368 Free article.

4

Repeated regression of pulmonary metastases from renal cell carcinoma after treatment using different interferon-alpha preparations.

Oya M, Asakura H, Mizuno R, Marumo K, Murai M. Oya M, et al. Biomed Res. 2005 Jun;26(3):135-7. doi: 10.2220/biomedres.26.135. Biomed Res. 2005. PMID: 16011307 Free article.

5

[Genetic backgrounds of renal cell carcinoma].

Oya M. Oya M. Nihon Rinsho. 2006 Feb;64 Suppl 2:593-6. Nihon Rinsho. 2006. PMID: 16523961 Review. Japanese. No abstract available.

6

[Treatment of renal cell carcinoma with interferons].

Oya M. Oya M. Nihon Rinsho. 2006 Jul;64(7):1281-5. Nihon Rinsho. 2006. PMID: 16838645 Review. Japanese.

7

Papillary renal cell carcinoma: clinicopathological characteristics in 40 patients.

Kosaka T, Mikami S, Miyajima A, Kikuchi E, Nakagawa K, Ohigashi T, Nakashima J, Oya M. Kosaka T, et al. Among authors: oya m. Clin Exp Nephrol. 2008 Jun;12(3):195-9. doi: 10.1007/s10157-008-0041-x. Epub 2008 Mar 7. Clin Exp Nephrol. 2008. PMID: 18324351

8

The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer.

Ide H, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T, Nakashima J, Oya M. Ide H, et al. Among authors: oya m. Jpn J Clin Oncol. 2008 May;38(5):360-4. doi: 10.1093/jjco/hyn036. Jpn J Clin Oncol. 2008. PMID: 18490370

9

Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma.

Kikuchi E, Margulis V, Karakiewicz PI, Roscigno M, Mikami S, Lotan Y, Remzi M, Bolenz C, Langner C, Weizer A, Montorsi F, Bensalah K, Koppie TM, Fernández MI, Raman JD, Kassouf W, Wood CG, Suardi N, Oya M, Shariat SF. Kikuchi E, et al. Among authors: oya m. J Clin Oncol. 2009 Feb 1;27(4):612-8. doi: 10.1200/JCO.2008.17.2361. Epub 2008 Dec 15. J Clin Oncol. 2009. PMID: 19075275 Free PMC article.

10

Gemcitabine and paclitaxel chemotherapy for advanced urothelial carcinoma in patients who have received prior cisplatin-based chemotherapy.

Kanai K, Kikuchi E, Ohigashi T, Miyajima A, Nakagawa K, Nakashima J, Oya M. Kanai K, et al. Among authors: oya m. Int J Clin Oncol. 2008 Dec;13(6):510-4. doi: 10.1007/s10147-008-0779-x. Epub 2008 Dec 18. Int J Clin Oncol. 2008. PMID: 19093178

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,205 results

Search Page